Citations (77)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Lucy Denly. (2021) The effect of sex on responses to influenza vaccines. Human Vaccines & Immunotherapeutics 17:5, pages 1396-1402.
Read now
Read now
Cécile van Els, Siri Mjaaland, Lisbeth Næss, Julia Sarkadi, Eva Gonczol, Karen Smith Korsholm, Jon Hansen, Jørgen de Jonge, Gideon Kersten, Jennifer Warner, Amanda Semper, Corine Kruiswijk & Fredrik Oftung. (2014) Fast vaccine design and development based on correlates of protection (COPs): Influenza as a trendsetter. Human Vaccines & Immunotherapeutics 10:7, pages 1935-1948.
Read now
Read now
Derrick Louz, Hans E. Bergmans, Birgit P. Loos & Rob C. Hoeben. (2013) Animal models in virus research: their utility and limitations. Critical Reviews in Microbiology 39:4, pages 325-361.
Read now
Read now
Maryna C Eichelberger & Martin D Green. (2011) Animal models to assess the toxicity, immunogenicity and effectiveness of candidate influenza vaccines. Expert Opinion on Drug Metabolism & Toxicology 7:9, pages 1117-1127.
Read now
Read now
Shengqiang Ge & Zhiliang Wang. (2011) An overview of Influenza A virus receptors. Critical Reviews in Microbiology 37:2, pages 157-165.
Read now
Read now
E Diane Williamson, MG Duchars & Robert Kohberger. (2010) Predictive models and correlates of protection for testing biodefence vaccines. Expert Review of Vaccines 9:5, pages 527-537.
Read now
Read now
Articles from other publishers (71)
Paritosh Patel, Aditya Nandi, Suresh K. Verma, Neha Kaushik, Mrutyunjay Suar, Eun Ha Choi & Nagendra Kumar Kaushik. (2023) Zebrafish-based platform for emerging bio-contaminants and virus inactivation research. Science of The Total Environment 872, pages 162197.
Crossref
Crossref
Mee Sook Park, Jin Il Kim, Joon-Yong Bae & Man-Seong Park. (2020) Animal models for the risk assessment of viral pandemic potential. Laboratory Animal Research 36:1.
Crossref
Crossref
Rob Lambkin‐Williams & John P. DeVincenzo. (2020) A COVID‐19 human viral challenge model. Learning from experience. Influenza and Other Respiratory Viruses 14:6, pages 747-756.
Crossref
Crossref
Christopher E. Lopez & Kevin L. Legge. (2020) Influenza A Virus Vaccination: Immunity, Protection, and Recent Advances Toward A Universal Vaccine. Vaccines 8:3, pages 434.
Crossref
Crossref
Irina Kiseleva, Andrey Rekstin, Mohammad Al Farroukh, Ekaterina Bazhenova, Anastasia Katelnikova, Ludmila Puchkova & Larisa Rudenko. (2020) Non-Mouse-Adapted H1N1pdm09 Virus as a Model for Influenza Research. Viruses 12:6, pages 590.
Crossref
Crossref
Thomas Ebensen, Kai Schulze, Blair Prochnow & Carlos Alberto Guzmán. 2019. Handbook of Immunosenescence. Handbook of Immunosenescence
39
62
.
Rob Lambkin-Williams, Nicolas Noulin, Alex Mann, Andrew Catchpole & Anthony S. Gilbert. (2018) The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics. Respiratory Research 19:1.
Crossref
Crossref
Leo Yi Yang Lee, Leonard Izzard & Aeron C. Hurt. (2018) A Review of DNA Vaccines Against Influenza. Frontiers in Immunology 9.
Crossref
Crossref
Ingrid Karlsson, Marie Borggren, Maiken Worsøe Rosenstierne, Ramona Trebbien, James A. Williams, Enric Vidal, Júlia Vergara-Alert, David Solanes Foz, Ayub Darji, Marta Sisteré-Oró, Joaquim Segalés, Jens Nielsen & Anders Fomsgaard. (2018) Protective effect of a polyvalent influenza DNA vaccine in pigs. Veterinary Immunology and Immunopathology 195, pages 25-32.
Crossref
Crossref
Thomas Ebensen, Kai Schulze, Blair Prochnow & Carlos Alberto Guzmán. 2017. Handbook of Immunosenescence. Handbook of Immunosenescence
1
24
.
Wen-Chun Liu, Raffael Nachbagauer, Florian Krammer & Randy A. Albrecht. 2018. Influenza Virus. Influenza Virus
487
511
.
M. D Heath, N. J. Swan, A. C. Marriott, N. J. Silman, B. Hallis, C. Prevosto, K. E. Gooch & M. A. Skinner. (2017) Comparison of a novel microcrystalline tyrosine adjuvant with aluminium hydroxide for enhancing vaccination against seasonal influenza. BMC Infectious Diseases 17:1.
Crossref
Crossref
. 2017. The Clinical Chemistry of Laboratory Animals. The Clinical Chemistry of Laboratory Animals
331
344
.
Brian J. Lenny, Stephanie Sonnberg, Angela F. Danner, Kimberly Friedman, Richard J. Webby, Robert G. Webster & Jeremy C. Jones. (2017) Evaluation of multivalent H2 influenza pandemic vaccines in mice. Vaccine 35:10, pages 1455-1463.
Crossref
Crossref
Sara I. Ruiz, Elizabeth E. Zumbrun & Aysegul Nalca. 2017. Animal Models for the Study of Human Disease. Animal Models for the Study of Human Disease
853
901
.
Hung-Hsun Yen & Helen M. S. Davies. (2016) Techniques for thoracic duct cannulation without thoracotomy in piglets. BMC Veterinary Research 12:1.
Crossref
Crossref
Almut H. Vollmer, Makda S. Gebre & Dale L. Barnard. (2016) Serum amyloid A (SAA) is an early biomarker of influenza virus disease in BALB/c, C57BL/2, Swiss-Webster, and DBA.2 mice. Antiviral Research 133, pages 196-207.
Crossref
Crossref
Elena Gianchecchi, Claudia Trombetta, Simona Piccirella & Emanuele Montomoli. (2016) Evaluating influenza vaccines: progress and perspectives. Future Virology 11:5, pages 379-393.
Crossref
Crossref
Daniel J. Fullen, Nicolas Noulin, Andrew Catchpole, Hosnieh Fathi, Edward J. Murray, Alex Mann, Kingsley Eze, Ganesh Balaratnam, Daryl W. Borley, Anthony Gilbert & Rob Lambkin-Williams. (2016) Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model. PLOS ONE 11:1, pages e0145902.
Crossref
Crossref
S. Pillet, T. Racine.C. Nfon, T.Z. Di Lenardo, S. Babiuk, B.J. Ward, G.P. Kobinger & N. Landry. (2015) Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets. Vaccine 33:46, pages 6282-6289.
Crossref
Crossref
Nani Wibowo, Yang Wu, Yuanyuan Fan, Joanne Meers, Linda H.L. Lua & Anton P.J. Middelberg. (2015) Non-chromatographic preparation of a bacterially produced single-shot modular virus-like particle capsomere vaccine for avian influenza. Vaccine 33:44, pages 5960-5965.
Crossref
Crossref
Kirk J. Maurer & Fred W. Quimby. 2015. Laboratory Animal Medicine. Laboratory Animal Medicine
1497
1534
.
Raphael Böhm, Thomas Haselhorst & Mark von Itzstein. 2015. Glycoscience: Biology and Medicine. Glycoscience: Biology and Medicine
749
767
.
Jin Lv, Dan Wang, Yan-Hong Hua, Shi-Jia Pei, Jin Wang, Wen-Wei Hu, Xi-Liang Wang, Na Jia & Qi-Sheng Jiang. (2014) Pulmonary immune responses to 2009 pandemic influenza A (H1N1) virus in mice. BMC Infectious Diseases 14:1.
Crossref
Crossref
Irina Margine & Florian Krammer. (2014) Animal Models for Influenza Viruses: Implications for Universal Vaccine Development. Pathogens 3:4, pages 845-874.
Crossref
Crossref
Thomas C. Nesspor & Bernard Scallon. (2014) Chimeric antibodies with extended half‐life in ferrets. Influenza and Other Respiratory Viruses 8:5, pages 596-604.
Crossref
Crossref
Rajagowthamee R. Thangavel & Nicole M. Bouvier. (2014) Animal models for influenza virus pathogenesis, transmission, and immunology. Journal of Immunological Methods 410, pages 60-79.
Crossref
Crossref
Alex J. Mann, Nicolas Noulin, Andrew Catchpole, Koert J. Stittelaar, Leon de Waal, Edwin J. B. Veldhuis Kroeze, Michael Hinchcliffe, Alan Smith, Emanuele Montomoli, Simona Piccirella, Albert D. M. E. Osterhaus, Alastair Knight, John S. Oxford, Giulia Lapini, Rebecca Cox & Rob Lambkin-Williams. (2014) Intranasal H5N1 Vaccines, Adjuvanted with Chitosan Derivatives, Protect Ferrets against Highly Pathogenic Influenza Intranasal and Intratracheal Challenge. PLoS ONE 9:5, pages e93761.
Crossref
Crossref
Matti Kiupel & David Perpiñán. 2014. Biology and Diseases of the Ferret. Biology and Diseases of the Ferret
439
517
.
Raphael Böhm, Thomas Haselhorst & Mark von Itzstein. 2021. Glycoscience: Biology and Medicine. Glycoscience: Biology and Medicine
1
18
.
Anice C. Lowen, Nicole M. Bouvier & John Steel. 2014. Influenza Pathogenesis and Control - Volume I. Influenza Pathogenesis and Control - Volume I
157
183
.
Ram P. Kamal, Jaqueline M. Katz & Ian A. York. 2014. Influenza Pathogenesis and Control - Volume I. Influenza Pathogenesis and Control - Volume I
243
274
.
Jin Il Kim, Sehee Park, Sangmoo Lee, Ilseob Lee, Jun Heo, Min-Woong Hwang, Joon-Yong Bae, Donghwan Kim, Seok-Il Jang, Mee Sook Park & Man-Seong Park. (2013) DBA/2 mouse as an animal model for anti-influenza drug efficacy evaluation. Journal of Microbiology 51:6, pages 866-871.
Crossref
Crossref
P. Noel Barrett, Daniel Portsmouth & Hartmut J. Ehrlich. 2013. Modern Biopharmaceuticals. Modern Biopharmaceuticals
349
386
.
Sara I. Ruiz, Elizabeth E. Zumbrun & Aysegul Nalca. 2013. Animal Models for the Study of Human Disease. Animal Models for the Study of Human Disease
927
970
.
Benjamin Petsch, Margit Schnee, Annette B Vogel, Elke Lange, Bernd Hoffmann, Daniel Voss, Thomas Schlake, Andreas Thess, Karl-Josef Kallen, Lothar Stitz & Thomas Kramps. (2012) Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection. Nature Biotechnology 30:12, pages 1210-1216.
Crossref
Crossref
Catharine M. Bosio, Megan MacLeod, Philippa Marrack & Ross M. Kedl. 2012. Vaccinology. Vaccinology
94
109
.
Annebel R. De Vleeschauwer, Benoît Baras, Constantinos S. Kyriakis, Valérie Jacob, Camille Planty, Sandra L. Giannini, Sally Mossman & Kristien Van Reeth. (2012) Efficacy of an AS03A-adjuvanted split H5N1 influenza vaccine against an antigenically distinct low pathogenic H5N1 virus in pigs. Vaccine 30:37, pages 5557-5563.
Crossref
Crossref
Sam D. Sanderson, Marilyn L. Thoman, Kornelia Kis, Elizabeth L. Virts, Edgar B. Herrera, Stephanie Widmann, Homero Sepulveda & Joy A. Phillips. (2012) Innate Immune Induction and Influenza Protection Elicited by a Response-Selective Agonist of Human C5a. PLoS ONE 7:7, pages e40303.
Crossref
Crossref
Danuta M. Skowronski, Marie-Eve Hamelin, Naveed Z. Janjua, Gaston De Serres, Jennifer L. Gardy, Chantal Rhéaume, Xavier Bouhy & Guy Boivin. (2012) Cross-Lineage Influenza B and Heterologous Influenza A Antibody Responses in Vaccinated Mice: Immunologic Interactions and B/Yamagata Dominance. PLoS ONE 7:6, pages e38929.
Crossref
Crossref
Jinxiang Wang, Xian Qi & Chengping Lu. (2012) Mutations in the C-terminal tail of NS1 protein facilitate the replication of classical swine H1N1 influenza A virus in mice. Folia Microbiologica 57:3, pages 169-175.
Crossref
Crossref
Brit N. J. Pourroy, Hans Jørn Kolmos & Lars P. Nielsen. (2012) Antibody administration in experimental influenza increases survival and enhances the effect of oseltamivir. Health 04:10, pages 933-940.
Crossref
Crossref
J?rgen Stech, Holger Garn, Astrid Herwig, Olga Stech, Bianca Dauber, Thorsten Wolff, Thomas C. Mettenleiter & Hans-Dieter Klenk. (2011) Influenza B Virus With Modified Hemagglutinin Cleavage Site as a Novel Attenuated Live Vaccine. The Journal of Infectious Diseases 204:10, pages 1483-1490.
Crossref
Crossref
Frank R. Jones, Elizabeth S. Gabitzsch, Younong Xu, Joseph P. Balint, Viktoriya Borisevich, Jennifer Smith, Jeanon Smith, Bi-Hung Peng, Aida Walker, Magda Salazar & Slobodan Paessler. (2011) Prevention of influenza virus shedding and protection from lethal H1N1 challenge using a consensus 2009 H1N1 HA and NA adenovirus vector vaccine. Vaccine 29:40, pages 7020-7026.
Crossref
Crossref
Rogier Bodewes, Joost H.C.M. Kreijtz, Geert van Amerongen, Ron A.M. Fouchier, Albert D.M.E. Osterhaus, Guus F. Rimmelzwaan & Thijs Kuiken. (2011) Pathogenesis of Influenza A/H5N1 Virus Infection in Ferrets Differs between Intranasal and Intratracheal Routes of Inoculation. The American Journal of Pathology 179:1, pages 30-36.
Crossref
Crossref
Jennifer Humberd SmithTamas NagyJamie BarberPaula BrooksS. Mark TompkinsRalph A. Tripp. (2011) Aerosol Inoculation with a Sub-lethal Influenza Virus Leads to Exacerbated Morbidity and Pulmonary Disease Pathogenesis. Viral Immunology 24:2, pages 131-142.
Crossref
Crossref
Donna M. Tscherne & Adolfo García-Sastre. (2011) Virulence determinants of pandemic influenza viruses. Journal of Clinical Investigation 121:1, pages 6-13.
Crossref
Crossref
Ruth V Bushnell, John K Tobin, Jinxue Long, Stacey Schultz-Cherry, A Ray Chaudhuri, Peter L Nara & Gregory J Tobin. (2010) Serological characterization of guinea pigs infected with H3N2 human influenza or immunized with hemagglutinin protein. Virology Journal 7:1.
Crossref
Crossref
Alexis McBrayer, Jeremy V Camp, Ron Tapp, Vladimir Yamshchikov, Sheila Grimes, Diana L Noah, Colleen B Jonsson & Carl E Bruder. (2010) Course of seasonal influenza A/Brisbane/59/07 H1N1 infection in the ferret. Virology Journal 7:1.
Crossref
Crossref
Crystal L. Loving, Susan L. Brockmeier, Amy L. Vincent, Mitchell V. Palmer, Randy E. Sacco & Tracy L. Nicholson. (2010) Influenza virus coinfection with Bordetella bronchiseptica enhances bacterial colonization and host responses exacerbating pulmonary lesions. Microbial Pathogenesis 49:5, pages 237-245.
Crossref
Crossref
Jean-Pierre Amorij, Wouter LJ Hinrichs, Henderik W Frijlink, Jan C Wilschut & Anke Huckriede. (2010) Needle-free influenza vaccination. The Lancet Infectious Diseases 10:10, pages 699-711.
Crossref
Crossref
Michela Rigoni, Anna Toffan, Elisabetta Viale, Marzia Mancin, Filippo Cilloni, Elena Bertoli, Angela Salomoni, Sabrina Marciano, Adelaide Milani, Bianca Zecchin, Ilaria Capua & Giovanni Cattoli. (2010) The mouse model is suitable for the study of viral factors governing transmission and pathogenesis of highly pathogenic avian influenza (HPAI) viruses in mammals. Veterinary Research 41:5, pages 66.
Crossref
Crossref
J. Theo M. Voeten, Irina V. Kiseleva, Harrie L. Glansbeek, Stephanie M. C. Basten, Sandra K. M. Drieszen-van der Cruijsen, Larisa G. Rudenko, Han van den Bosch & Jacco G. M. Heldens. (2010) Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model. Archives of Virology 155:9, pages 1391-1399.
Crossref
Crossref
Chih-Jen WeiJeffrey C. BoyingtonPatrick M. McTamneyWing-Pui KongMelissa B. PearceLing XuHanne AndersenSrinivas RaoTerrence M. TumpeyZhi-Yong YangGary J. Nabel. (2010) Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination. Science 329:5995, pages 1060-1064.
Crossref
Crossref
Koert J. Stittelaar, Valérie Lacombe, Rob van Lavieren, Geert van Amerongen, James Simon, Valérie Cozette, David E. Swayne, Hervé Poulet & Albert D.M.E. Osterhaus. (2010) Cross-clade immunity in cats vaccinated with a canarypox-vectored avian influenza vaccine. Vaccine 28:31, pages 4970-4976.
Crossref
Crossref
Elizabeth B. Norton, John D. Clements, Thomas G. Voss & Lucia Cárdenas-Freytag. (2010) Prophylactic Administration of Bacterially Derived Immunomodulators Improves the Outcome of Influenza Virus Infection in a Murine Model. Journal of Virology 84:6, pages 2983-2995.
Crossref
Crossref
Penghui Yang, Li Xing, Chong Tang, Weihong Jia, Zhongpeng Zhao, Kun Liu, Xiao Gao & Xiliang Wang. (2010) Response of BALB/c mice to a monovalent influenza A (H1N1) 2009 split vaccine. Cellular & Molecular Immunology 7:2, pages 116-122.
Crossref
Crossref
Joshua M. DiNapoli, Baibaswata Nayak, Lijuan Yang, Brad W. Finneyfrock, Anthony Cook, Hanne Andersen, Fernando Torres-Velez, Brian R. Murphy, Siba K. Samal, Peter L. Collins & Alexander Bukreyev. (2010) Newcastle Disease Virus-Vectored Vaccines Expressing the Hemagglutinin or Neuraminidase Protein of H5N1 Highly Pathogenic Avian Influenza Virus Protect against Virus Challenge in Monkeys. Journal of Virology 84:3, pages 1489-1503.
Crossref
Crossref
Danylo Sirskyj, Richard Weltzin, Ashkan Golshani, David Anderson, Jasminka Bozic, Francisco Diaz-Mitoma & Ali Azizi. (2010) Detection of influenza A and B neutralizing antibodies in vaccinated ferrets and macaques using specific biotin–streptavidin conjugated antibodies. Journal of Virological Methods 163:2, pages 459-464.
Crossref
Crossref
Giuseppe Del GiudiceKoert J. StittelaarGeert van AmerongenJames SimonAlbert D. M. E. OsterhausKlaus StöhrRino Rappuoli. (2009) Seasonal Influenza Vaccine Provides Priming for A/H1N1 Immunization. Science Translational Medicine 1:12.
Crossref
Crossref
Jennifer C. Woo & Christopher S. Ambrose. (2009) Concomitant administration of seasonal trivalent and pandemic monovalent H1N1 live attenuated influenza vaccines. Influenza and Other Respiratory Viruses 3:6, pages 257-259.
Crossref
Crossref
Kristien Van Reeth, Debby Braeckmans, Eric Cox, Steven Van Borm, Thierry van den Berg, Bruno Goddeeris & Annebel De Vleeschauwer. (2009) Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus. Vaccine 27:45, pages 6330-6339.
Crossref
Crossref
S. Kirkeby, C.J.M. Martel & B. Aasted. (2009) Infection with human H1N1 influenza virus affects the expression of sialic acids of metaplastic mucous cells in the ferret airways. Virus Research 144:1-2, pages 225-232.
Crossref
Crossref
David Verhoeven, John R. Teijaro & Donna L. Farber. (2009) Pulse-oximetry accurately predicts lung pathology and the immune response during influenza infection. Virology 390:2, pages 151-156.
Crossref
Crossref
Zachary Shriver, Rahul Raman, Karthik Viswanathan & Ram Sasisekharan. (2009) Context-Specific Target Definition in Influenza A Virus Hemagglutinin-Glycan Receptor Interactions. Chemistry & Biology 16:8, pages 803-814.
Crossref
Crossref
Dale L. Barnard. (2009) Animal models for the study of influenza pathogenesis and therapy. Antiviral Research 82:2, pages A110-A122.
Crossref
Crossref
Yumiko Matsuoka, Elaine W. Lamirande & Kanta Subbarao. (2009) The Mouse Model for Influenza. Current Protocols in Microbiology 13:1.
Crossref
Crossref
Yumiko Matsuoka, Elaine W. Lamirande & Kanta Subbarao. (2009) The Ferret Model for Influenza. Current Protocols in Microbiology 13:1.
Crossref
Crossref
Daniela Kugel, Georg Kochs, Karola Obojes, Joachim Roth, Gary P. Kobinger, Darwyn Kobasa, Otto Haller, Peter Staeheli & Veronika von Messling. (2009) Intranasal Administration of Alpha Interferon Reduces Seasonal Influenza A Virus Morbidity in Ferrets. Journal of Virology 83:8, pages 3843-3851.
Crossref
Crossref
Neal Van Hoeven, Jessica A. Belser, Kristy J. Szretter, Hui Zeng, Peter Staeheli, David E. Swayne, Jacqueline M. Katz & Terrence M. Tumpey. (2009) Pathogenesis of 1918 Pandemic and H5N1 Influenza Virus Infections in a Guinea Pig Model: Antiviral Potential of Exogenous Alpha Interferon To Reduce Virus Shedding. Journal of Virology 83:7, pages 2851-2861.
Crossref
Crossref
Constantinos S. Kyriakis, Annebel De Vleeschauwer, Filip Barbé, Michel Bublot & Kristien Van Reeth. (2009) Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs. Vaccine 27:16, pages 2258-2264.
Crossref
Crossref